03/29/2026
Did you know that Ozempic — the diabetes and weight-loss drug — may also reduce alcohol cravings?
It's not a coincidence. GLP-1 receptors are present in the brain's reward center, the same circuit that drives craving and compulsive use. When semaglutide acts on those receptors, it dampens the dopamine response to alcohol and other substances. A clinical trial published in 2024 found a 40% reduction in weekly alcohol consumption among people with alcohol use disorder taking semaglutide.
Dr. Drew Edwards explains the neuroscience behind this finding — and what it means for people in recovery who are still struggling with persistent craving: https://www.neurogenesisproject.com/blog/glp1-semaglutide-addiction-brain-cravings
Have you or someone you know experienced this? We'd love to hear from you in the comments.